Dr.SleepRoch said:It helps to say which part of this you are uncertain about.
Second this. I had assumed I was the exception until I read this.
Dr.SleepRoch said:It helps to say which part of this you are uncertain about.
Second this. I had assumed I was the exception until I read this.
DataDave said:Give anything pharmacological four weeks before you judge it, and give anything measured weekly a four-point rolling average before you call it a…
That is right for the common case. Whether it is right for the case being asked about depends on a detail that has not been given.
DataDave said:Give anything pharmacological four weeks before you judge it, and give anything measured weekly a four-point rolling average before you call it a…
That reframing is the part I needed. Adding it to my notes with a link back to this thread.
Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.
View ResultsAdding the clinical framing, because it changes how the question reads. The useful move here is to separate what is established from what is widely repeated. Those two sets overlap less than the confident tone of most write-ups suggests, and the second set is where nearly all the disagreement on this board comes from.
Moderator note: the sourcing question belongs in the vendor section and has been split out. Thread quality here is what the rules are for. Keep it up.